OTC Markets OTCPK - Delayed Quote USD
BioInvent International AB (publ) (BOVNF)
4.7000
0.0000
(0.00%)
At close: May 19 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
60,804
44,686
71,461
326,126
19,384
Operating Expense
565,126
515,934
442,018
376,598
297,549
Operating Income
-504,322
-471,248
-370,557
-50,472
-278,165
Net Non Operating Interest Income Expense
--
41,535
39,967
8,422
-253
Pretax Income
-467,920
-429,240
-330,100
-42,503
-278,444
Tax Provision
141
135
204
0
0
Net Income Common Stockholders
-468,061
-429,375
-330,304
-42,503
-278,444
Diluted NI Available to Com Stockholders
-468,061
-429,375
-330,304
-42,503
-278,444
Basic EPS
-6.53
--
-5.02
-0.69
-5.14
Diluted EPS
-6.53
--
-5.02
-0.69
-5.14
Basic Average Shares
65,804
--
65,767
61,521
54,161
Diluted Average Shares
65,804
--
65,767
61,521
54,161
Total Operating Income as Reported
-504,133
-471,059
-369,942
-50,921
-278,350
Total Expenses
565,126
515,934
442,018
376,598
297,549
Net Income from Continuing & Discontinued Operation
-468,061
-429,375
-330,304
-42,503
-278,444
Normalized Income
-464,697.4000
-429,375
-330,304
-42,503
-278,444
Interest Income
--
42,090
40,605
9,072
264
Interest Expense
--
555
638
650
517
Net Interest Income
--
41,535
39,967
8,422
-253
EBIT
-461,759
-428,685
-329,462
-41,853
-277,927
EBITDA
-450,092
-417,443
-320,199
-27,129
-263,317
Reconciled Depreciation
11,667
11,242
9,263
14,724
14,610
Net Income from Continuing Operation Net Minority Interest
-468,061
-429,375
-330,304
-42,503
-278,444
Total Unusual Items Excluding Goodwill
-5,606
41,819
39,842
--
--
Total Unusual Items
-5,606
41,819
39,842
--
--
Normalized EBITDA
-444,486
-417,443
-320,199
-27,129
-263,317
Tax Rate for Calcs
0.0004
0.0002
0.0002
0
0
Tax Effect of Unusual Items
-2,242.4000
0
0
0
0
12/31/2021 - 9/3/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade